PATENT CLAIM ANALYSIS

Application Number: 16046531
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2019-01
Patent Classification: ["424", "474000"]

Abstract:
The present invention relates to a pharmaceutical composition comprising a physical mixture of sacubitril sodium and valsartan disodium, wherein the X-ray powder diffraction pattern of valsartan disodium comprises characteristic peaks at the following 2 theta (±0.2) angles: 4.70°, 9.29°, 22.34°, measured using a Cu Kα radiation. The invention further relates to the use of said pharmaceutical composition as medicament in the treatment of heart failure.

Claim (Index 21):
Pharmaceutical composition comprising valsartan disodium according to  claim 17 .

Metadata:
- Claim Count in Document: 29.0
- Percentile: 95.0
- Lexical Diversity: 1.37037
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15752943', '15568550', '15735717', '15755733', '16060297']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7318591748135114
- 35 USC 102 Novelty (BERT): 0.4885486493796227
- Combined Prediction Score: 0.7075281222701225
- Mean Citation Score: 209.473668
- Max Citation Score: 226.50926
- Similarity Product: 172.3198617917955

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test